MedTrace Logo

CSD170301: An Unblinded, Parallel, Randomized Study to Assess Nicotine Uptake in Smokers From Four Different Electronic Cigarettes

NCT03105804 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 144

Last updated 2018-04-10

No results posted yet for this study

Summary

To determine the rate and amount of nicotine uptake with 10-minute ad libitum use of four different marketed electronic cigarettes. Furthermore, to measure overall product liking by subjects to assess potential willingness to seek out the Electronic Cigarette (EC) again in the future.

Conditions

  • Smoking

Interventions

OTHER

FT21039

An electronic cigarette

OTHER

FT21041

An electronic cigarette

OTHER

FT21044

An electronic cigarette

OTHER

FT21042

An electronic cigarette

Sponsors & Collaborators

  • Inflamax Research Incorporated

    collaborator INDUSTRY

  • Davita Clinical Research

    collaborator INDUSTRY

  • RAI Services Company

    lead INDUSTRY

Principal Investigators

  • Frank Lee, MD · Inflamax Research Incorporated

  • Margarita Nunez, MD · High Point Clinical Trial Center

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-03-29
Primary Completion
2017-10-27
Completion
2017-10-27

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03105804 on ClinicalTrials.gov